Cargando…
Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990975/ http://dx.doi.org/10.1186/2051-1426-1-S1-O20 |
_version_ | 1782312357371838464 |
---|---|
author | Leong, Meredith Kanne, David Glickman, Laura Lemmens, Edward Lauer, Peter Metchette, Ken Burdette, Dara Diner, Elie Fu, Juan Soares, Kevin Brockstedt, Dirk Portnoy, Daniel Vance, Russell Kim, Young Jaffee, Elizabeth Pardoll, Drew Dubensky, Thomas |
author_facet | Leong, Meredith Kanne, David Glickman, Laura Lemmens, Edward Lauer, Peter Metchette, Ken Burdette, Dara Diner, Elie Fu, Juan Soares, Kevin Brockstedt, Dirk Portnoy, Daniel Vance, Russell Kim, Young Jaffee, Elizabeth Pardoll, Drew Dubensky, Thomas |
author_sort | Leong, Meredith |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3990975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39909752014-05-01 Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines Leong, Meredith Kanne, David Glickman, Laura Lemmens, Edward Lauer, Peter Metchette, Ken Burdette, Dara Diner, Elie Fu, Juan Soares, Kevin Brockstedt, Dirk Portnoy, Daniel Vance, Russell Kim, Young Jaffee, Elizabeth Pardoll, Drew Dubensky, Thomas J Immunother Cancer Oral Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990975/ http://dx.doi.org/10.1186/2051-1426-1-S1-O20 Text en Copyright © 2013 Leong et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Presentation Leong, Meredith Kanne, David Glickman, Laura Lemmens, Edward Lauer, Peter Metchette, Ken Burdette, Dara Diner, Elie Fu, Juan Soares, Kevin Brockstedt, Dirk Portnoy, Daniel Vance, Russell Kim, Young Jaffee, Elizabeth Pardoll, Drew Dubensky, Thomas Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines |
title | Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines |
title_full | Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines |
title_fullStr | Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines |
title_full_unstemmed | Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines |
title_short | Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines |
title_sort | modified sting-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990975/ http://dx.doi.org/10.1186/2051-1426-1-S1-O20 |
work_keys_str_mv | AT leongmeredith modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT kannedavid modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT glickmanlaura modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT lemmensedward modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT lauerpeter modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT metchetteken modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT burdettedara modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT dinerelie modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT fujuan modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT soareskevin modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT brockstedtdirk modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT portnoydaniel modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT vancerussell modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT kimyoung modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT jaffeeelizabeth modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT pardolldrew modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines AT dubenskythomas modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines |